Probiotics as a Treatment Strategy for Gastrointestinal Diseases?
- 1 September 2005
- journal article
- review article
- Published by S. Karger AG in Digestion
- Vol. 72 (1) , 57-68
- https://doi.org/10.1159/000087638
Abstract
Current interest in probiotics is motivated not only by the clinical data showing efficacy of some probiotic bacteria but also by the increasing antibiotic resistance of pathogenic bacteria (particularly in hospitals) and the rise of consumers' demand for natural substitutes of drugs. Only few randomized, double-blind placebo-controlled human trials are available, and some involved only small numbers of patients. They are difficult to compare because of differences in probiotic strains employed, doses and formulation. Among probiotic applications, reduction of diarrhea is probably the best-documented effect confirmed by recent meta-analyses. Literature on Helicobacter pylori indicates that probiotics are unable to eradicate the infection but could be useful in decreasing infection levels and as adjuvants of therapy-associated side effects. Studies performed in inflammatory bowel disease suggest that high doses of probiotics and most likely a combination of different lactobacilli and bifidobacteria are more effective in decreasing inflammatory score and maintaining patients in remission than a single probiotic strain. Probiotic studies evaluating amelioration of symptoms in irritable bowel syndrome would require more sustained patient numbers. However, accumulated data is encouraging and suggests that efficacy is strain-dependent. Finally, too few probiotic intervention trials have been reported on colon cancer to allow any firm conclusion.Keywords
This publication has 90 references indexed in Scilit:
- Bacillus clausii therapy to reduce side‐effects of anti‐Helicobacter pylori treatment: randomized, double‐blind, placebo controlled trialAlimentary Pharmacology & Therapeutics, 2004
- New pathophysiological mechanisms in irritable bowel syndromeAlimentary Pharmacology & Therapeutics, 2004
- VSL3 probiotic mixture induces remission in patients with active ulcerative colitisGastroenterology, 2003
- A review of the role of the gut microflora in irritable bowel syndrome and the effects of probioticsBritish Journal of Nutrition, 2002
- A placebo-controlled trial of Lactobacillus GG to prevent diarrhea in undernourished Peruvian childrenThe Journal of Pediatrics, 1999
- Lactobacillus‐ and bifidobacterium‐mediated antigenotoxicity in the colon of ratsNutrition and Cancer, 1996
- The effect ofLactobacillusGG on the initiation and promotion of DMH‐induced intestinal tumors in the ratNutrition and Cancer, 1996
- The Protective Effect of Human Milk against Diarrhea: A Review of Studies from BangladeshActa Paediatrica, 1989
- Protection against Cholera in Breast-Fed Children by Antibodies in Breast MilkNew England Journal of Medicine, 1983
- Controlled trial of orally administered lactobacilli in acute infantile diarrheaThe Journal of Pediatrics, 1974